After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Keros Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Keros Therapeutics Inc is $479.61M. A total of 1.49 million shares were traded on the day, compared to an average of 1.40M shares.
In the most recent transaction, GORDON CARL L sold 250,000 shares of KROS for 44.01 per share on Aug 13 ’24. After the transaction, the Director now owns 119,522 company shares. In a previous transaction on Aug 13 ’24, ORBIMED ADVISORS LLC sold 250,000 shares at 44.01 per share. KROS shares that Director owns now total 119,522.
Among the insiders who bought shares, OrbiMed Genesis Master Fund, L acquired of 29,400 shares on Aug 13 ’24 at a per-share price of $44.84. In another insider transaction, OrbiMed Private Investments VI bought 220,600 shares at $44.84 per share on Aug 13 ’24.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, KROS has a high of $73.00 and a low of $9.77.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. KROS’s latest balance sheet shows that the firm has $230.04M in Cash & Short Term Investments as of fiscal 2021. There were $1.09M in debt and $11.85M in liabilities at the time. Its Book Value Per Share was $13.57, while its Total Shareholder’s Equity was $243.17M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KROS is Buy with a score of 4.20.
